tailieunhanh - Belotecan/cisplatin versus etoposide/ cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: A multi-center randomized phase III trial

No novel chemotherapeutic combinations have demonstrated superior efficacy to etoposide/cisplatin (EP), a standard treatment regimen for extensive-stage small cell lung carcinoma (ES-SCLC) over the past decade. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN